|
CDC25A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.87880000005014E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.30009999619463E-08 |
| Normal-vs-Stage2 |
1.71019999994915E-06 |
| Normal-vs-Stage3 |
3.59370000002635E-06 |
| Normal-vs-Stage4 |
5.931600E-01 |
| Stage1-vs-Stage2 |
9.891400E-01 |
| Stage1-vs-Stage3 |
6.182200E-01 |
| Stage1-vs-Stage4 |
1.047820E-02 |
| Stage2-vs-Stage3 |
6.910600E-01 |
| Stage2-vs-Stage4 |
1.477860E-02 |
| Stage3-vs-Stage4 |
2.495700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.09259999994771E-06 |
| Normal-vs-AfricanAmerican |
4.578600E-03 |
| Normal-vs-Asian |
9.221200E-01 |
| Caucasian-vs-AfricanAmerican |
4.657600E-01 |
| Caucasian-vs-Asian |
1.252830E-01 |
| AfricanAmerican-vs-Asian |
2.434400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.36970000000647E-05 |
| Normal-vs-Female |
8.06440000000741E-07 |
| Male-vs-Female |
9.726800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.042400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.72389999999667E-05 |
| Normal-vs-Age(61-80Yrs) |
1.59939999999636E-05 |
| Normal-vs-Age(81-100Yrs) |
1.9892799999921E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.701580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.435370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.410400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.839000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.632000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.603400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.337800E-02 |
| Normal-vs-Grade 2 |
2.35829999972736E-08 |
| Normal-vs-Grade 3 |
7.05159999947469E-07 |
| Normal-vs-Grade 4 |
9.541200E-01 |
| Grade 1-vs-Grade 2 |
6.784600E-01 |
| Grade 1-vs-Grade 3 |
8.545600E-01 |
| Grade 1-vs-Grade 4 |
1.375210E-01 |
| Grade 2-vs-Grade 3 |
2.802000E-01 |
| Grade 2-vs-Grade 4 |
4.160500E-03 |
| Grade 3-vs-Grade 4 |
1.050200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.09430292289426E-11 |
| Normal-vs-ccB subtype |
6.116200E-03 |
| ccA subtype-vs-ccB subtype |
1.10119999996439E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.57340000000295E-05 |
| Normal-vs-N1 |
5.245200E-01 |
| N0-vs-N1 |
6.737700E-02 |
|
|
